Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Comparing collagen injection to placebo for knee osteoarthritis

Official title: Hydrolyzed Collagen Formulation Versus Placebo in the Treatment of Degenerative Knee Cartilage Injuries

Run by Istituto Ortopedico Rizzoli · NCT04998188 · Data updated 2026-11-12

This study is testing if a single injection of collagen can help people with knee osteoarthritis feel better compared to a placebo shot.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment204 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedFebruary 16, 2022
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedFebruary 3, 2026
Trial IDNCT04998188 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with unilateral knee osteoarthritis who have not responded to conservative treatments.

Probably not a fit

Patients with recent knee surgeries, other significant medical conditions, or those who have received other intra-articular injections in the past 6 months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a single intra-articular injection of hydrolyzed collagen compared to a placebo (saline solution) in patients with knee osteoarthritis. A total of 204 participants will be randomly assigned to receive either the collagen injection or the placebo, with follow-up assessments conducted at 1, 3, and 6 months post-injection. Clinical evaluations will include both subjective questionnaires and objective measures such as thermographic assessments to monitor inflammation. After 6 months, participants in the placebo group will have the option to switch to the collagen treatment for an additional 6 months of follow-up.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective option for managing knee osteoarthritis symptoms.

How similar studies have gone: While similar approaches have been explored, this specific formulation and method of administration is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Unilateral involvement;
2. Signs and symptoms of degenerative pathology of knee cartilage;
3. Radiographic and MRI signs of degenerative pathology of the knee cartilage (Kellgren-Lawrence 1-4 grades);
4. Failure, defined as the persistence of symptoms, after at least one course of conservative treatment (pharmacological, physiotherapeutic or infiltrative treatment);
5. Ability and consent of patients to actively participate in clinical follow-up;

Exclusion Criteria:

1. Patients who have undergone intra-articular injections of another substance in the previous 6 months;
2. Patients undergoing knee surgery within the previous 12 months;
3. Patients with malignant neoplasms;
4. Patients with rheumatic diseases;
5. Patients with diabetes;
6. Patients with hematologic diseases (coagulopathies);
7. Patients on anticoagulant therapy;
8. Patients with metabolic disorders of the thyroid gland;
9. Patients abusing alcoholic beverages, drugs or medications;
10. Body Mass Index \> 35;
11. Pregnant or lactating women.
12. Patients with established hypersensitivity to bovine collagen or vitamin C.
13. Patients with joint or peri-articular infections, emarto, erythema, or psoriatic patches in the knee joint area

Where it's running

  • Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Alessandro Di Martino, MD — Istituto Ortopedico Rizzoli
  • Study coordinator: Roberta Licciardi, Msc
  • Email: roberta.licciardi@ior.it
  • Phone: 0516366567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.